Primary cancer definition

Primary cancer means a cancer defined by the original body site at which the cancer was incurred, prior to any spread (metastasis) resulting in tu- mors at other sites in the body.
Sample 1Sample 2Sample 3
Primary cancer means a cancerdefined by the original body site at which the cancer was incurred, prior to any spread (metastasis) resulting in tumors at other sites in the body.
Sample 1Sample 2
Primary cancer means a cancer defined by the original body site at which the cancer was incurred, prior to any spread (metastasis) to other sites in the body.
Sample 1

Examples of Primary cancer in a sentence

  • Primary cancer of the lung, pro- vided onset occurred at least five years after first exposure.

  • Primary cancer prevention strategy involves changes of behaviour or habits that reduce a risk, for example, stopping smoking, fat reduction in the diet, etc.

  • Primary cancer of the: (A) Thyroid; (B) male or female breast; (C) esophagus; (D) stomach; (E) pharynx, including all three areas, oropharynx, nasopharynx, and hypopharynx and the larynx.

  • Primary cancer site was grouped into 4 categories - proximal colon (caecum, appendix, ascending colon, hepatic flexure, transverse colon), distal colon (splenic flexure, descending colon, sigmoid colon), colon NOS (including overlapping lesions of the colon), and rectum (including the rectosigmoid junction).

  • Primary cancer is according to the tissue it originates from, for instance colorectal cancer af- fects large intestine and rectum, gastric cancer originates from the stomach, and endometrial cancer originates from the endometrium.

  • We will not pay under this particular crisis condition for any of the following: Primary cancer of the breast, prostate, skin or bowel (these are covered in a separate definition); or AIDS related cancers; or Tumours which are histologically described as pre-malignant or showing malignant changes of carcinoma in situ.

  • We will not pay under this particular crisis condition for any of the following:  Primary cancer of the breast, prostate, skin or bowel (these are covered in a separate definition); or Tumours which are confirmed as pre-malignant or showing malignant changes of ‘carcinoma in situ’ and not requiring major surgery; or AIDS related cancers.

  • We will not pay under this particular crisis condition for any of the following: Primary cancer of the breast, prostate, skin or bowel (these are covered in a separate definition); or AIDS related cancers; or Tumours which are histologically described as pre-malignant or showing malignant changes of ’carcinoma in situ.’ However, if the tumour either produces permanentsignificant functional impairment or requires major surgery for its removal, then we would consider a claim application.

  • The Process efficiency and tube displacement are found to be improved exponentially with increasing in coupling factor.

  • Hepatocellular carcinoma (HCC): Primary cancer of the liver arising from the hepatocytes and may be a complication of chronic hepatitis B or C infection.

Related to Primary cancer

  • Primary care physician or “PCP” means a Plan Provider who has an independent contractor agreement with HPN to assume responsibility for arranging and coordinating the delivery of Covered Services to Members. A Primary Care Physician’s agreement with HPN may terminate. In the event that a Member’s Primary Care Physician’s agreement terminates, the Member will be required to select another Primary Care Physician.

  • primary carer means the person who has responsibility for the care of the Child. Only one person can be the Child’s Primary Carer on a particular day.

  • Primary Care Provider (PCP) means a health care professional who is contracted with BCBSAZ as a PCP and generally specializes in or focuses on the following practice areas: internal medicine, family practice, general practice, pediatrics or any other classification of provider approved as a PCP by BCBSAZ. Your benefit plan does not require you to have a PCP or to have a PCP authorize specialist referrals.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Stage-Four Advanced, Metastatic Cancer means a cancer that has spread from the primary or original site of the cancer to nearby tissues, lymph nodes, or other areas or parts of the body.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Primary caregiver or "caregiver" means a resident of the State

  • Medical evaluation means the process of assessing an individual's health status that includes a medical history and a physical examination of an individual conducted by a licensed medical practitioner operating within the scope of his license.

  • Objective medical evidence means reports of examinations or treatments; medical

  • Medical cannabis dispensary means an organization issued a

  • Phase IV Clinical Trial means a Clinical Trial conducted after a Product achieves Regulatory Approval, carried out for purposes of conducting safety surveillance and ongoing technical support of the Product.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Biological diversity means the variability among living organisms from all sources including, inter alia, terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they are part; this includes diversity within species, between species and of ecosystems.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Biological safety cabinet means a containment unit suitable for the preparation of low to moderate risk agents where there is a need for protection of the product, personnel, and environment, according to National Sanitation Foundation (NSF) Standard 49.

  • Hospice patient s family" means a hospice patient's immediate family members, including a spouse, brother, sister, child, or parent, and any other relative or individual who has significant personal ties to the patient and who is designated as a member of the patient's family by mutual agreement of the patient, the relative or individual, and the patient's interdisciplinary team.

  • Independent educational evaluation means an evaluation conducted by a qualified examiner who is not employed by the public agency responsible for the education of the child in question.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • Primary care giver" means a person who assumes the principal role of providing care and attention to a child.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.